nylidrin has been researched along with Infant, Newborn, Diseases in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eggimann, UH | 1 |
| Thürig, E | 1 |
| Moser, H | 1 |
| Bossi, E | 1 |
1 other study available for nylidrin and Infant, Newborn, Diseases
| Article | Year |
|---|---|
[Threatened abortion: patient characteristics, treatment results and consequences for the child].
Topics: Abortion, Threatened; Congenital Abnormalities; Diazepam; Dydrogesterone; Female; Hexestrol; Humans; | 1979 |